Chronic kidney disease refers to the protracted course of renal damage. As it is an obstinate disease, to get retrieval, sufferers from it often try diverse treatments. Sometimes, the improper treatment not only cannot offer the patients pleasing outcomes, but also hasten the deterioration of their ailment, which will make our kidneys impaired further. Demand for kidney transplants is snowballing. In the western world, high blood pressure and type II diabetes are going up and are contributing to higher rates of kidney disease. But there are not sufficient donor organs to meet this mounting requisite. Stem cell based therapies might offer an alternative solution.
Scientists are reviewing how the kidney can regenerate itself and what kinds of kidney cells are involved in this procedure. It is still not clear which kind of cells are involved in kidney regeneration. There are numerous groups of cells around nephrons that have ‘stem cell like’ features. One category is called Renal Progenitor Cells (RPC), another group has characteristics similar to mesenchymal stem cells (MSCs), cells normally found in bone marrow.Kidney ailments can be triggered by mutilation to diverse kinds of cells in the kidney. Stem cell treatments will only be effective if they contemplate which cells are impaired and must be replaced. Cell treatments that encourage natural repair paths could happen quicker than cell replacement therapies, but investigators still need a better understanding of how the natural repair procedures works before treatments can be devised.